PF-514273

• Description:

  PF-514273 is an orally active, selective antagonist for cannabinoid-1 receptor (CB1) with IC50 of 1 nM. PF-514273 reduces the food uptake in mice, and can be used for obesity research[1].

• UNSPSC:

  12352005

• Target:

  Cannabinoid Receptor

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Field of Research:

  Metabolic Disease

• Smiles:

  O=C1N(CC(F)(F)C)CCOC2=C(C3=CC=C(Cl)C=C3)N(C4=CC=CC=C4Cl)N=C12

• Molecular Formula:

  C21H17Cl2F2N3O2

• Molecular Weight:

  452.28

• References & Citations:

  [1]Dow RL, et al., Discovery of 2- (2-chlorophenyl) -3- (4-chlorophenyl) -7- (2,2-difluoropropyl) -6,7-dihydro-2H-pyrazolo[3,4-f][1,4]oxazepin-8 (5H) -one (PF-514273), a novel, bicyclic lactam-based cannabinoid-1 receptor antagonist for the treatment of obesity. J Med Chem. 2009 May 14;52 (9) :2652-5.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  Phase 1

• CAS Number:

  [851728-60-4]